Premium
Use of eculizumab in refractory gemcitabine‐induced thrombotic microangiopathy
Author(s) -
Starck Michael,
Wendtner ClemensMartin
Publication year - 2014
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12686
Subject(s) - thrombotic microangiopathy , medicine , eculizumab , gemcitabine , rituximab , microangiopathic hemolytic anemia , gastroenterology , thrombotic thrombocytopenic purpura , adamts13 , prednisolone , oncology , chemotherapy , immunology , lymphoma , platelet , complement system , antibody , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom